Pesquisa: GHRP-6

Growth hormone secretagogue — strong GH release, strongest hunger effect

GHRP-6 Research Papers & Clinical Studies

GHRP-6 is a peptide studied for its potential therapeutic effects. Growth hormone secretagogue — strong GH release, strongest hunger effect This page indexes all published research papers, clinical trials, and scientific studies related to GHRP-6 that are available in the PepsReview research library. Each paper includes metadata such as journal name, publication year, citation count, study type, and a summary of key findings. Where available, we provide direct links to the original publication and DOI references.

Researchers can use this index to quickly locate evidence supporting specific GHRP-6 applications, compare study designs, and evaluate the strength of clinical evidence. Papers are sorted by relevance and citation count. There are currently 5 research papers indexed for GHRP-6.

For vendor pricing, user reviews, and a complete peptide profile including mechanism of action, benefits, side effects, and regulatory status, visit the main GHRP-6 profile page.

GHRP-6

Regulation of growth hormone secretion by the growth hormone releasing hexapeptide (GHRP-6)

J Pediatr Endocrinol 1993 660 Research Article

Study investigating GHRP-6's role in regulating growth hormone secretion, examining mechanisms by which this hexapeptide modulates pituitary GH release.

Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency

J Pediatr Endocrinol Metab 1996 600 Research Article

GHRP-6 testing showed lower GH responses in GH-deficient children vs normal children, but with considerable overlap between groups, limiting diagnostic specificity.

Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism

Clin Endocrinol (Oxf) 1997 580 Research Article

Study investigating growth hormone responses to GHRP-6 in hypothyroidism, examining how thyroid status affects GH secretagogue-stimulated hormone release.

Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms

Front Pharmacol 2024 40 Research Article

GHRP-6 administration concomitant to doxorubicin prevented cardiotoxicity and dilated cardiomyopathy by activating prosurvival mechanisms, offering cardioprotection.

Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation

J Nanobiotechnology 2025 20 Research Article

GHRP-6 hydrogel targets metabolic reprogramming of renal tubular epithelial cells to promote recovery and prevent fibrosis after acute kidney injury.